These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 30789699)

  • 1. Surgical Tumor-Derived Personalized Photothermal Vaccine Formulation for Cancer Immunotherapy.
    Ye X; Liang X; Chen Q; Miao Q; Chen X; Zhang X; Mei L
    ACS Nano; 2019 Mar; 13(3):2956-2968. PubMed ID: 30789699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photothermal cancer immunotherapy by erythrocyte membrane-coated black phosphorus formulation.
    Liang X; Ye X; Wang C; Xing C; Miao Q; Xie Z; Chen X; Zhang X; Zhang H; Mei L
    J Control Release; 2019 Feb; 296():150-161. PubMed ID: 30682441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Endogenous Vaccine Based on Fluorophores and Multivalent Immunoadjuvants Regulates Tumor Micro-Environment for Synergistic Photothermal and Immunotherapy.
    Li L; Yang S; Song L; Zeng Y; He T; Wang N; Yu C; Yin T; Liu L; Wei X; Wu Q; Wei Y; Yang L; Gong C
    Theranostics; 2018; 8(3):860-873. PubMed ID: 29344312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced antitumor immunity by targeting dendritic cells with tumor cell lysate-loaded chitosan nanoparticles vaccine.
    Shi GN; Zhang CN; Xu R; Niu JF; Song HJ; Zhang XY; Wang WW; Wang YM; Li C; Wei XQ; Kong DL
    Biomaterials; 2017 Jan; 113():191-202. PubMed ID: 27816821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The enhanced antitumor-specific immune response with mannose- and CpG-ODN-coated liposomes delivering TRP2 peptide.
    Lai C; Duan S; Ye F; Hou X; Li X; Zhao J; Yu X; Hu Z; Tang Z; Mo F; Yang X; Lu X
    Theranostics; 2018; 8(6):1723-1739. PubMed ID: 29556352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ photothermal nano-vaccine based on tumor cell membrane-coated black phosphorus-Au for photo-immunotherapy of metastatic breast tumors.
    Huang D; Wu T; Lan S; Liu C; Guo Z; Zhang W
    Biomaterials; 2022 Oct; 289():121808. PubMed ID: 36137415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-assembly nanovaccine containing TLR7/8 agonist and STAT3 inhibitor enhances tumor immunotherapy by augmenting tumor-specific immune response.
    Zhang L; Huang J; Chen X; Pan C; He Y; Su R; Guo D; Yin S; Wang S; Zhou L; Chen J; Zheng S; Qiao Y
    J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34452929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel membrane-bound GM-CSF vaccines for the treatment of cancer: generation and evaluation of mbGM-CSF mouse B16F10 melanoma cell vaccine.
    Yei S; Bartholomew RM; Pezzoli P; Gutierrez A; Gouveia E; Bassett D; Soo Hoo W; Carlo DJ
    Gene Ther; 2002 Oct; 9(19):1302-11. PubMed ID: 12224013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant IL-7 enhances the potency of GM-CSF-secreting tumor cell immunotherapy.
    Li B; VanRoey MJ; Jooss K
    Clin Immunol; 2007 May; 123(2):155-65. PubMed ID: 17320482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
    Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
    Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomimetic black phosphorus quantum dots-based photothermal therapy combined with anti-PD-L1 treatment inhibits recurrence and metastasis in triple-negative breast cancer.
    Zhao P; Xu Y; Ji W; Zhou S; Li L; Qiu L; Qian Z; Wang X; Zhang H
    J Nanobiotechnology; 2021 Jun; 19(1):181. PubMed ID: 34120612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenic Cell Death Amplified by Co-localized Adjuvant Delivery for Cancer Immunotherapy.
    Fan Y; Kuai R; Xu Y; Ochyl LJ; Irvine DJ; Moon JJ
    Nano Lett; 2017 Dec; 17(12):7387-7393. PubMed ID: 29144754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laser Immunotherapy in Combination with Perdurable PD-1 Blocking for the Treatment of Metastatic Tumors.
    Luo L; Zhu C; Yin H; Jiang M; Zhang J; Qin B; Luo Z; Yuan X; Yang J; Li W; Du Y; You J
    ACS Nano; 2018 Aug; 12(8):7647-7662. PubMed ID: 30020768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining photothermal therapy and immunotherapy against melanoma by polydopamine-coated Al
    Chen W; Qin M; Chen X; Wang Q; Zhang Z; Sun X
    Theranostics; 2018; 8(8):2229-2241. PubMed ID: 29721075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen.
    Wculek SK; Amores-Iniesta J; Conde-Garrosa R; Khouili SC; Melero I; Sancho D
    J Immunother Cancer; 2019 Apr; 7(1):100. PubMed ID: 30961656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomes Encapsulating Neoantigens and Black Phosphorus Quantum Dots for Enhancing Photothermal Immunotherapy.
    Zhang J; Chen X; Xue T; Cheng Q; Ye X; Wang C; Yu Y; Ji X; Wu M; Zhang X; Zheng Y; Wu B; Liang X; Mei L
    J Biomed Nanotechnol; 2020 Sep; 16(9):1394-1405. PubMed ID: 33419493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil infiltration and whole-cell vaccine elicited by N-dihydrogalactochitosan combined with NIR phototherapy to enhance antitumor immune response and T cell immune memory.
    Qi S; Lu L; Zhou F; Chen Y; Xu M; Chen L; Yu X; Chen WR; Zhang Z
    Theranostics; 2020; 10(4):1814-1832. PubMed ID: 32042338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy of established tumour with a hybrid cellular vaccine generated by using granulocyte-macrophage colony-stimulating factor genetically modified dendritic cells.
    Cao X; Zhang W; Wang J; Zhang M; Huang X; Hamada H; Chen W
    Immunology; 1999 Aug; 97(4):616-25. PubMed ID: 10457215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Black Phosphorus Quantum Dot Loaded Bioinspired Nanoplatform Synergized with aPD-L1 for Multimode Cancer Immunotherapy.
    Cao Y; Tang L; Fu C; Yin Y; Liu H; Feng J; Gao J; Shu W; Li Z; Zhu Y; Wang W
    Nano Lett; 2024 Jun; 24(22):6767-6777. PubMed ID: 38771956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of genetically modified dendritic cells and tumor cells as therapeutic cancer vaccines.
    Klein C; Bueler H; Mulligan RC
    J Exp Med; 2000 May; 191(10):1699-708. PubMed ID: 10811863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.